1558.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 02:20):

Stats
Today's Volume	1.47M
Average Volume	2.87M
Market Cap	8.42B
EPS	HKD0 ( 2024-03-28 )
Next earnings date	( HKD0 ) 2024-06-07
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	3.86
ATR14	HKD0.0170 (0.18%)

Volume Correlation

Long: -0.14 (neutral)

Short: -0.01 (neutral)

Signal:(28.599) Neutral

YiChang HEC ChangJiang Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YiChang HEC ChangJiang Correlation - Currency/Commodity

0.72
( moderate )

0.76
( moderate )

0.00
( neutral )

0.55
( weak )

0.22
( neutral )

YiChang HEC ChangJiang Financials

Annual	2023
Revenue:	HKD6.29B
Gross Profit:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
Revenue:	HKD6.29B
Gross Profit:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
Revenue:	HKD3.74B
Gross Profit:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
Revenue:	HKD913.79M
Gross Profit:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.39%) | Divividend Growth Potential Score: 4.45 - Potential for dividend initiation, but uncertain (11.06%)

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	3.14	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.45
Div. Directional Score	6.84	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.14

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1963.HK	Ex Dividend Junior	2023-06-26	Annually	0.00%
0842.HK	Ex Dividend Junior	2023-09-04	Sporadic	0.00%
3818.HK	Ex Dividend Knight	2023-08-21	Annually	0.00%
1448.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
0369.HK	Ex Dividend Junior	2023-09-14	Semi-Annually	0.00%
2177.HK	Ex Dividend Junior	2023-09-12	Sporadic	0.00%
0992.HK	Ex Dividend Knight	2023-07-26	Semi-Annually	0.00%
0012.HK	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
6178.HK	Ex Dividend Junior	2023-07-12	Annually	0.00%
1626.HK	Ex Dividend Junior	2023-06-21	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.505	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	0.443	1.000	3.13	3.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.641	1.000	7.55	7.55	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.06	1.000	9.69	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.505	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.393	1.500	-0.716	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.266	1.000	5.85	0	[0.1 - 0.5]
Total Score				4.45

YiChang HEC ChangJiang Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.

Realtime updates for YiChang HEC ChangJiang [1558.HK]

Upcoming Earnings Alert